
Clinical Chemistry Analyzers: Global Markets
Description
Clinical Chemistry Analyzers: Global Markets
Report Scope:
This report examines the current and forecast market potential for clinical chemistry analyzers, in terms of product, modality and end user.
By product, the market is segmented into semi-automated and fully automated analyzers. By modality, the market is segmented into benchtop, standalone and handheld/portable. By end user, the market is segmented into hospitals and clinics, diagnostic labs, research institutes and others.
By geography, the market has been segmented into Europe, North America, Asia-Pacific (APAC) and Rest of the World (RoW). Major countries analyzed include the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China. For market estimates, data is provided for 2021 as the base year, 2022, and the forecast through year-end 2027. Estimates are based on manufacturers’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
29 data tables
An up-to-date overview and analysis of the global market for clinical chemistry analyzers
Analyses of the global market trends, with sales data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Evaluation and forecast the market size for clinical chemistry analysers, projected growth trends, and corresponding market share analysis segmented by product category, modality, end user, and geographic region
Updated information on key market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence the demand in the coming years (2022-2027)
Discussion of the industry value chain analysis providing a systematic study of the key intermediaries involved, which could further assist stakeholders in formulating appropriate strategies
In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
Updated information on the mergers, acquisitions, agreements, collaborations, product launches, achievements and partnerships in the global market for clinical chemistry analysers
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading global players, including JEOL Ltd., Abbott Diagnostics Division, Danaher Corp. and Sysmex America inc.
Report Scope:
This report examines the current and forecast market potential for clinical chemistry analyzers, in terms of product, modality and end user.
By product, the market is segmented into semi-automated and fully automated analyzers. By modality, the market is segmented into benchtop, standalone and handheld/portable. By end user, the market is segmented into hospitals and clinics, diagnostic labs, research institutes and others.
By geography, the market has been segmented into Europe, North America, Asia-Pacific (APAC) and Rest of the World (RoW). Major countries analyzed include the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China. For market estimates, data is provided for 2021 as the base year, 2022, and the forecast through year-end 2027. Estimates are based on manufacturers’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
29 data tables
An up-to-date overview and analysis of the global market for clinical chemistry analyzers
Analyses of the global market trends, with sales data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Evaluation and forecast the market size for clinical chemistry analysers, projected growth trends, and corresponding market share analysis segmented by product category, modality, end user, and geographic region
Updated information on key market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence the demand in the coming years (2022-2027)
Discussion of the industry value chain analysis providing a systematic study of the key intermediaries involved, which could further assist stakeholders in formulating appropriate strategies
In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
Updated information on the mergers, acquisitions, agreements, collaborations, product launches, achievements and partnerships in the global market for clinical chemistry analysers
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading global players, including JEOL Ltd., Abbott Diagnostics Division, Danaher Corp. and Sysmex America inc.
Table of Contents
93 Pages
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing this Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Highlights of the Analysis of the Market
- Chapter 3 Regulatory Scenario
- U.S.
- Canada
- Regulations in Europe
- Regulations in Asia-Pacific
- Japan
- China
- India
- Australia and New Zealand
- Malaysia
- Singapore
- Regulations in RoW (Latin America, Middle East and Africa)
- Brazil
- Mexico
- Israel
- Saudi Arabia
- South Africa
- Chapter 4 Market Background
- History of Clinical Chemistry
- The Rise of Automation
- Today's Analyzers
- Future of Clinical Chemistry Analyzers
- Clinical Chemistry Tests
- Blood Gas, Electrolytes and Metabolites (BGEM)
- Endocrine
- Urinalysis
- Chapter 5 Market Dynamics
- Market Drivers
- Rising Aging Population and Global Incidence of Chronic Diseases
- Common Types of Chronic Diseases
- Growing Need for Preventive Diagnostics
- Point-of-Care Tests
- Market Restraints
- Growing Tax Burdens on Medical Devices
- Stringent Regulatory Frameworks
- High Cost of R&D and Marketing
- Chapter 6 Impact of COVID-19 Pandemic
- Impact of COVID-19 on Clinical Chemistry Analyzers
- Chapter 7 Market Breakdown by Product Category
- Introduction
- Semiautomated Clinical Chemistry Analyzers
- Fully Automated Clinical Chemistry Analyzers
- Chapter 8 Market Breakdown by Modality
- Introduction
- Benchtop
- Standalone
- Handheld/Portable
- Chapter 9 Market Breakdown by End User
- Introduction
- Hospitals and Clinics
- Diagnostic Labs
- Research Institutes
- Other End Users
- Chapter 10 Market Breakdown by Region
- Intoduction
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
- Chapter 11 Competitive Landscape
- Company Market Shares
- Recent News
- Chapter 12 Company Profiles
- ABBOTT DIAGNOSTICS DIVISION
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- JEOL LTD.
- SIEMENS HEALTHINEERS
- SYSMEX AMERICA INC.
- THERMO FISHER SCIENTIFIC INC.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.